These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Protecting rights to early-stage technology. Shuster MJ; Su H; Blaug S Nat Biotechnol; 2003 Jun; 21(6):701-3. PubMed ID: 12776151 [No Abstract] [Full Text] [Related]
23. Medical devices: partnering for success. Reynolds K Australas Phys Eng Sci Med; 2009 Dec; 32(4):xi-xii. PubMed ID: 20169834 [No Abstract] [Full Text] [Related]
24. Is Bayh-Dole good for developing countries? Lessons from the US experience. So AD; Sampat BN; Rai AK; Cook-Deegan R; Reichman JH; Weissman R; Kapczynski A PLoS Biol; 2008 Oct; 6(10):e262. PubMed ID: 18959484 [TBL] [Abstract][Full Text] [Related]
25. Universities, business, and the state government: partners in progress. Edlich RF J Emerg Med; 1992; 10(5):617-21. PubMed ID: 1401866 [No Abstract] [Full Text] [Related]
30. Use the Bayh-Dole Act to lower drug prices for government healthcare programs. Engelberg AB; Kesselheim AS Nat Med; 2016 Jun; 22(6):576. PubMed ID: 27270771 [No Abstract] [Full Text] [Related]
31. Found in translation; from the laboratory to the operating room to the market. Galloway RL Annu Int Conf IEEE Eng Med Biol Soc; 2007; 2007():5162-5. PubMed ID: 18003170 [TBL] [Abstract][Full Text] [Related]
33. Patent and license pearls and pitfalls for taking an idea to the marketplace. Mukharji I J Investig Med; 2011 Jun; 59(5):758-61. PubMed ID: 21441827 [TBL] [Abstract][Full Text] [Related]
34. Intellectual property and biotechnology: the U.S. internal experience--Part I. Brody B Kennedy Inst Ethics J; 2006 Mar; 16(1):1-37. PubMed ID: 16770885 [TBL] [Abstract][Full Text] [Related]
35. Technology transfer. Rutherford JJ IEEE Eng Med Biol Mag; 2010; 29(2):12-6. PubMed ID: 20659836 [TBL] [Abstract][Full Text] [Related]
37. Quick response technology: the key to outstanding growth. Knorr RO; Neuman JL J Bus Strategy; 1992; 13(5):61-4. PubMed ID: 10121464 [No Abstract] [Full Text] [Related]
38. Building relationships with technology transfer officers. Das OP Nat Biotechnol; 2005 Jul; 23(7):781-3. PubMed ID: 16075476 [No Abstract] [Full Text] [Related]
39. [Patent rights and the free research. The boundary between basic research and private sector is not longer razor-sharp]. Westerlund L Lakartidningen; 2005 Sep 26-Oct 2; 102(39):2737. PubMed ID: 16245544 [No Abstract] [Full Text] [Related]
40. The stem-cell market - patents and the pursuit of scientific progress. Murray F N Engl J Med; 2007 Jun; 356(23):2341-3. PubMed ID: 17554114 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]